A detailed history of Voloridge Investment Management, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 286,186 shares of HRMY stock, worth $9.94 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
286,186
Previous 335,425 14.68%
Holding current value
$9.94 Million
Previous $10.1 Million 12.99%
% of portfolio
0.04%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.0 - $39.95 $1.48 Million - $1.97 Million
-49,239 Reduced 14.68%
286,186 $11.4 Million
Q2 2024

Aug 14, 2024

SELL
$28.81 - $33.01 $311,176 - $356,541
-10,801 Reduced 3.12%
335,425 $10.1 Million
Q1 2024

May 15, 2024

SELL
$29.93 - $35.06 $1.96 Million - $2.3 Million
-65,578 Reduced 15.92%
346,226 $11.6 Million
Q4 2023

Feb 14, 2024

BUY
$19.2 - $33.78 $2.74 Million - $4.82 Million
142,637 Added 52.99%
411,804 $13.3 Million
Q3 2023

Nov 14, 2023

BUY
$31.89 - $39.03 $607,345 - $743,326
19,045 Added 7.61%
269,167 $8.82 Million
Q2 2023

Aug 14, 2023

BUY
$30.5 - $37.4 $4.48 Million - $5.5 Million
146,937 Added 142.4%
250,122 $8.8 Million
Q1 2023

May 15, 2023

BUY
$30.8 - $53.92 $3.05 Million - $5.34 Million
98,999 Added 2365.0%
103,185 $3.37 Million
Q4 2022

Feb 14, 2023

SELL
$45.4 - $60.91 $872,315 - $1.17 Million
-19,214 Reduced 82.11%
4,186 $230,000
Q3 2022

Nov 14, 2022

SELL
$42.06 - $55.45 $1.52 Million - $2 Million
-36,113 Reduced 60.68%
23,400 $1.04 Million
Q2 2022

Aug 15, 2022

SELL
$33.54 - $52.15 $4.48 Million - $6.96 Million
-133,460 Reduced 69.16%
59,513 $2.9 Million
Q1 2022

May 16, 2022

BUY
$33.14 - $51.13 $4.62 Million - $7.13 Million
139,433 Added 260.43%
192,973 $9.39 Million
Q4 2021

Feb 14, 2022

BUY
$34.09 - $43.91 $1.83 Million - $2.35 Million
53,540 New
53,540 $2.28 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.05B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.